nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0132	0.0315	CcSEcCtD
Leflunomide—Digestion impaired—Ramipril—type 1 diabetes mellitus	0.0124	0.0297	CcSEcCtD
Leflunomide—Neuralgia—Ramipril—type 1 diabetes mellitus	0.012	0.0285	CcSEcCtD
Leflunomide—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.01	0.0239	CcSEcCtD
Leflunomide—Liver injury—Ramipril—type 1 diabetes mellitus	0.00989	0.0236	CcSEcCtD
Leflunomide—Cough increased—Ramipril—type 1 diabetes mellitus	0.00909	0.0217	CcSEcCtD
Leflunomide—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00852	0.0203	CcSEcCtD
Leflunomide—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00832	0.0198	CcSEcCtD
Leflunomide—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00756	0.018	CcSEcCtD
Leflunomide—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00698	0.0166	CcSEcCtD
Leflunomide—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00681	0.0162	CcSEcCtD
Leflunomide—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00672	0.016	CcSEcCtD
Leflunomide—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00624	0.0149	CcSEcCtD
Leflunomide—Arthritis—Ramipril—type 1 diabetes mellitus	0.00621	0.0148	CcSEcCtD
Leflunomide—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00558	0.0133	CcSEcCtD
Leflunomide—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00546	0.013	CcSEcCtD
Leflunomide—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00544	0.013	CcSEcCtD
Leflunomide—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00544	0.013	CcSEcCtD
Leflunomide—Gastritis—Ramipril—type 1 diabetes mellitus	0.00534	0.0127	CcSEcCtD
Leflunomide—Asthma—Ramipril—type 1 diabetes mellitus	0.00522	0.0124	CcSEcCtD
Leflunomide—Influenza—Ramipril—type 1 diabetes mellitus	0.00522	0.0124	CcSEcCtD
Leflunomide—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00517	0.0123	CcSEcCtD
Leflunomide—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00512	0.0122	CcSEcCtD
Leflunomide—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00508	0.0121	CcSEcCtD
Leflunomide—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00508	0.0121	CcSEcCtD
Leflunomide—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00502	0.012	CcSEcCtD
Leflunomide—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00496	0.0118	CcSEcCtD
Leflunomide—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00488	0.0116	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00485	0.0116	CcSEcCtD
Leflunomide—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00461	0.011	CcSEcCtD
Leflunomide—Renal failure—Ramipril—type 1 diabetes mellitus	0.00457	0.0109	CcSEcCtD
Leflunomide—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00456	0.0109	CcSEcCtD
Leflunomide—Jaundice—Ramipril—type 1 diabetes mellitus	0.00454	0.0108	CcSEcCtD
Leflunomide—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00454	0.0108	CcSEcCtD
Leflunomide—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00452	0.0108	CcSEcCtD
Leflunomide—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00452	0.0108	CcSEcCtD
Leflunomide—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.0044	0.0105	CcSEcCtD
Leflunomide—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00439	0.0105	CcSEcCtD
Leflunomide—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00437	0.0104	CcSEcCtD
Leflunomide—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00434	0.0104	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.00428	0.00738	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—SH2B3—type 1 diabetes mellitus	0.00423	0.00729	CbGpPWpGaD
Leflunomide—PTK2B—Endothelins—PRKCQ—type 1 diabetes mellitus	0.00421	0.00726	CbGpPWpGaD
Leflunomide—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00418	0.00996	CcSEcCtD
Leflunomide—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00412	0.00981	CcSEcCtD
Leflunomide—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00411	0.00979	CcSEcCtD
Leflunomide—ABCG2—Iron uptake and transport—CP—type 1 diabetes mellitus	0.00399	0.00687	CbGpPWpGaD
Leflunomide—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00395	0.00942	CcSEcCtD
Leflunomide—PTK2B—Interleukin-2 signaling—IL2RA—type 1 diabetes mellitus	0.00394	0.00679	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—ITPR3—type 1 diabetes mellitus	0.00392	0.00675	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—CBLB—type 1 diabetes mellitus	0.00379	0.00653	CbGpPWpGaD
Leflunomide—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00377	0.00899	CcSEcCtD
Leflunomide—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00377	0.00897	CcSEcCtD
Leflunomide—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00373	0.0089	CcSEcCtD
Leflunomide—PTK2B—Signaling by VEGF—ITPR3—type 1 diabetes mellitus	0.0037	0.00637	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—ERBB3—type 1 diabetes mellitus	0.0037	0.00637	CbGpPWpGaD
Leflunomide—Alopecia—Ramipril—type 1 diabetes mellitus	0.00369	0.0088	CcSEcCtD
Leflunomide—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00366	0.00872	CcSEcCtD
Leflunomide—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00364	0.00867	CcSEcCtD
Leflunomide—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00356	0.00849	CcSEcCtD
Leflunomide—PTK2B—IL2-mediated signaling events—IL2RA—type 1 diabetes mellitus	0.00353	0.00608	CbGpPWpGaD
Leflunomide—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.0035	0.00833	CcSEcCtD
Leflunomide—AHR—Adipogenesis—E2F1—type 1 diabetes mellitus	0.00346	0.00595	CbGpPWpGaD
Leflunomide—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00337	0.00804	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNGR2—type 1 diabetes mellitus	0.00333	0.00574	CbGpPWpGaD
Leflunomide—Angioedema—Ramipril—type 1 diabetes mellitus	0.00332	0.00792	CcSEcCtD
Leflunomide—Malaise—Ramipril—type 1 diabetes mellitus	0.00328	0.00782	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.00328	0.00565	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.00328	0.00565	CbGpPWpGaD
Leflunomide—Vertigo—Ramipril—type 1 diabetes mellitus	0.00327	0.00779	CcSEcCtD
Leflunomide—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00326	0.00776	CcSEcCtD
Leflunomide—PTK2B—CXCR4-mediated signaling events—VAV1—type 1 diabetes mellitus	0.00325	0.0056	CbGpPWpGaD
Leflunomide—PTK2B—IL-7 Signaling Pathway—STAT3—type 1 diabetes mellitus	0.00322	0.00555	CbGpPWpGaD
Leflunomide—Palpitations—Ramipril—type 1 diabetes mellitus	0.00321	0.00766	CcSEcCtD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—FGF21—type 1 diabetes mellitus	0.00318	0.00549	CbGpPWpGaD
Leflunomide—Cough—Ramipril—type 1 diabetes mellitus	0.00317	0.00756	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—PRKCQ—type 1 diabetes mellitus	0.00317	0.00546	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.00312	0.00538	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.00312	0.00538	CbGpPWpGaD
Leflunomide—Chest pain—Ramipril—type 1 diabetes mellitus	0.0031	0.00738	CcSEcCtD
Leflunomide—Arthralgia—Ramipril—type 1 diabetes mellitus	0.0031	0.00738	CcSEcCtD
Leflunomide—Myalgia—Ramipril—type 1 diabetes mellitus	0.0031	0.00738	CcSEcCtD
Leflunomide—Anxiety—Ramipril—type 1 diabetes mellitus	0.00309	0.00735	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—VAV1—type 1 diabetes mellitus	0.00308	0.0053	CbGpPWpGaD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00308	0.00733	CcSEcCtD
Leflunomide—AHR—Integrated Breast Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00307	0.00528	CbGpPWpGaD
Leflunomide—Discomfort—Ramipril—type 1 diabetes mellitus	0.00306	0.00729	CcSEcCtD
Leflunomide—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00303	0.00722	CcSEcCtD
Leflunomide—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00297	0.00707	CcSEcCtD
Leflunomide—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00291	0.00694	CcSEcCtD
Leflunomide—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00291	0.00693	CcSEcCtD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—IGFBP1—type 1 diabetes mellitus	0.0029	0.005	CbGpPWpGaD
Leflunomide—Tachycardia—Ramipril—type 1 diabetes mellitus	0.0029	0.0069	CcSEcCtD
Leflunomide—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00288	0.00687	CcSEcCtD
Leflunomide—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00287	0.00684	CcSEcCtD
Leflunomide—Anorexia—Ramipril—type 1 diabetes mellitus	0.00283	0.00674	CcSEcCtD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—CP—type 1 diabetes mellitus	0.00283	0.00487	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—TYK2—type 1 diabetes mellitus	0.00278	0.00479	CbGpPWpGaD
Leflunomide—Hypotension—Ramipril—type 1 diabetes mellitus	0.00277	0.00661	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.0027	0.00645	CcSEcCtD
Leflunomide—Insomnia—Ramipril—type 1 diabetes mellitus	0.00268	0.0064	CcSEcCtD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—VAV1—type 1 diabetes mellitus	0.00268	0.00462	CbGpPWpGaD
Leflunomide—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00267	0.00635	CcSEcCtD
Leflunomide—PTK2B—Signaling by Interleukins—VAV1—type 1 diabetes mellitus	0.00266	0.00458	CbGpPWpGaD
Leflunomide—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00265	0.00631	CcSEcCtD
Leflunomide—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00261	0.00623	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—CD8A—type 1 diabetes mellitus	0.0026	0.00448	CbGpPWpGaD
Leflunomide—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00258	0.00615	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00256	0.00611	CcSEcCtD
Leflunomide—Fatigue—Ramipril—type 1 diabetes mellitus	0.00256	0.0061	CcSEcCtD
Leflunomide—Constipation—Ramipril—type 1 diabetes mellitus	0.00254	0.00605	CcSEcCtD
Leflunomide—PTK2B—IL-2 Signaling Pathway—IL2—type 1 diabetes mellitus	0.00253	0.00436	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—VAV1—type 1 diabetes mellitus	0.00253	0.00436	CbGpPWpGaD
Leflunomide—PTK2B—Signaling of Hepatocyte Growth Factor Receptor—STAT3—type 1 diabetes mellitus	0.00252	0.00434	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—INS—type 1 diabetes mellitus	0.00251	0.00433	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—CDK4—type 1 diabetes mellitus	0.0025	0.00431	CbGpPWpGaD
Leflunomide—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00245	0.00583	CcSEcCtD
Leflunomide—AHR—Adipogenesis—IGF1—type 1 diabetes mellitus	0.00243	0.00418	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00243	0.00579	CcSEcCtD
Leflunomide—DHODH—Metabolism—HBA2—type 1 diabetes mellitus	0.00242	0.00417	CbGpPWpGaD
Leflunomide—PTK2B—Integrins in angiogenesis—IGF1—type 1 diabetes mellitus	0.00238	0.0041	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CCR5—type 1 diabetes mellitus	0.00238	0.0041	CbGpPWpGaD
Leflunomide—Urticaria—Ramipril—type 1 diabetes mellitus	0.00236	0.00562	CcSEcCtD
Leflunomide—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00235	0.00559	CcSEcCtD
Leflunomide—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00235	0.00559	CcSEcCtD
Leflunomide—PTK2B—IL2-mediated signaling events—IFNG—type 1 diabetes mellitus	0.00233	0.00401	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL2—type 1 diabetes mellitus	0.00231	0.00398	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—G6PC2—type 1 diabetes mellitus	0.00228	0.00392	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1R1—type 1 diabetes mellitus	0.00225	0.00388	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—HLA-DRB1—type 1 diabetes mellitus	0.00224	0.00386	CbGpPWpGaD
Leflunomide—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00219	0.00521	CcSEcCtD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—TYK2—type 1 diabetes mellitus	0.00214	0.00369	CbGpPWpGaD
Leflunomide—Asthenia—Ramipril—type 1 diabetes mellitus	0.00213	0.00508	CcSEcCtD
Leflunomide—PTK2B—IL-2 Signaling Pathway—STAT3—type 1 diabetes mellitus	0.00213	0.00367	CbGpPWpGaD
Leflunomide—Pruritus—Ramipril—type 1 diabetes mellitus	0.0021	0.00501	CcSEcCtD
Leflunomide—PTK2B—IL2-mediated signaling events—IL2—type 1 diabetes mellitus	0.00207	0.00356	CbGpPWpGaD
Leflunomide—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00203	0.00484	CcSEcCtD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—type 1 diabetes mellitus	0.00203	0.0035	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL2RA—type 1 diabetes mellitus	0.00203	0.00349	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.00199	0.00343	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ABCC8—type 1 diabetes mellitus	0.00197	0.0034	CbGpPWpGaD
Leflunomide—Dizziness—Ramipril—type 1 diabetes mellitus	0.00196	0.00468	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.00193	0.00333	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—VAV1—type 1 diabetes mellitus	0.00192	0.00331	CbGpPWpGaD
Leflunomide—Vomiting—Ramipril—type 1 diabetes mellitus	0.00189	0.0045	CcSEcCtD
Leflunomide—Rash—Ramipril—type 1 diabetes mellitus	0.00187	0.00446	CcSEcCtD
Leflunomide—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00187	0.00446	CcSEcCtD
Leflunomide—Headache—Ramipril—type 1 diabetes mellitus	0.00186	0.00443	CcSEcCtD
Leflunomide—CYP1A2—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	0.00183	0.00314	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—CASP3—type 1 diabetes mellitus	0.00181	0.00312	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—CASP3—type 1 diabetes mellitus	0.00179	0.00308	CbGpPWpGaD
Leflunomide—Nausea—Ramipril—type 1 diabetes mellitus	0.00176	0.0042	CcSEcCtD
Leflunomide—PTK2B—FGF signaling pathway—STAT3—type 1 diabetes mellitus	0.00174	0.003	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—STAT3—type 1 diabetes mellitus	0.00174	0.003	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—type 1 diabetes mellitus	0.00167	0.00288	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—CASP3—type 1 diabetes mellitus	0.00166	0.00286	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—PTPN2—type 1 diabetes mellitus	0.00165	0.00284	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—B2M—type 1 diabetes mellitus	0.00163	0.00281	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—E2F1—type 1 diabetes mellitus	0.00159	0.00274	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—CD4—type 1 diabetes mellitus	0.00158	0.00272	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—STAT3—type 1 diabetes mellitus	0.00157	0.00271	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00156	0.00269	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—type 1 diabetes mellitus	0.00153	0.00264	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—STAT3—type 1 diabetes mellitus	0.0015	0.00259	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CD4—type 1 diabetes mellitus	0.00149	0.00257	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DPB1—type 1 diabetes mellitus	0.00144	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—TYK2—type 1 diabetes mellitus	0.00144	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTSH—type 1 diabetes mellitus	0.00144	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—OAS1—type 1 diabetes mellitus	0.00144	0.00248	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—TYK2—type 1 diabetes mellitus	0.00143	0.00246	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-E—type 1 diabetes mellitus	0.00142	0.00244	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—NOS3—type 1 diabetes mellitus	0.00141	0.00243	CbGpPWpGaD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00138	0.00238	CbGpPWpGaD
Leflunomide—PTK2B—LPA receptor mediated events—EGFR—type 1 diabetes mellitus	0.00138	0.00238	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1B—type 1 diabetes mellitus	0.00138	0.00238	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—type 1 diabetes mellitus	0.00136	0.00234	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL6—type 1 diabetes mellitus	0.00136	0.00234	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—TYK2—type 1 diabetes mellitus	0.00136	0.00234	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—NOS3—type 1 diabetes mellitus	0.00133	0.0023	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ITPR3—type 1 diabetes mellitus	0.00132	0.00227	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.0013	0.00223	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—EGFR—type 1 diabetes mellitus	0.00127	0.00218	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—VAV1—type 1 diabetes mellitus	0.00124	0.00214	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—HBA1—type 1 diabetes mellitus	0.00124	0.00213	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—APOC3—type 1 diabetes mellitus	0.00123	0.00212	CbGpPWpGaD
Leflunomide—PTK2B—CXCR4-mediated signaling events—STAT3—type 1 diabetes mellitus	0.00122	0.00211	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GSTT1—type 1 diabetes mellitus	0.00121	0.00208	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.0012	0.00207	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DQA1—type 1 diabetes mellitus	0.0012	0.00207	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1B—type 1 diabetes mellitus	0.00119	0.00205	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL2—type 1 diabetes mellitus	0.00119	0.00205	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00118	0.00204	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DQB1—type 1 diabetes mellitus	0.00112	0.00194	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IL6—type 1 diabetes mellitus	0.0011	0.00189	CbGpPWpGaD
Leflunomide—CYP1A2—Estrogen Receptor Pathway—STAT3—type 1 diabetes mellitus	0.00109	0.00188	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNGR2—type 1 diabetes mellitus	0.00109	0.00188	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD226—type 1 diabetes mellitus	0.00109	0.00188	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—NOS3—type 1 diabetes mellitus	0.00101	0.00175	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-B—type 1 diabetes mellitus	0.00101	0.00174	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—STAT3—type 1 diabetes mellitus	0.001	0.00172	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GCG—type 1 diabetes mellitus	0.000963	0.00166	CbGpPWpGaD
Leflunomide—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000956	0.00165	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2RA—type 1 diabetes mellitus	0.000946	0.00163	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000945	0.00163	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-A—type 1 diabetes mellitus	0.000935	0.00161	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000874	0.00151	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DRB1—type 1 diabetes mellitus	0.000854	0.00147	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.000844	0.00145	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CAT—type 1 diabetes mellitus	0.000816	0.00141	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—type 1 diabetes mellitus	0.000808	0.00139	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CBLB—type 1 diabetes mellitus	0.000799	0.00138	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000794	0.00137	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000786	0.00135	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000774	0.00133	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—SELL—type 1 diabetes mellitus	0.000755	0.0013	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1R1—type 1 diabetes mellitus	0.000736	0.00127	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—STAT3—type 1 diabetes mellitus	0.000723	0.00125	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—type 1 diabetes mellitus	0.000704	0.00121	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—type 1 diabetes mellitus	0.000698	0.0012	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000681	0.00117	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—TYK2—type 1 diabetes mellitus	0.000666	0.00115	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—type 1 diabetes mellitus	0.000664	0.00114	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000657	0.00113	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNG—type 1 diabetes mellitus	0.000624	0.00108	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—LGALS3—type 1 diabetes mellitus	0.00062	0.00107	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ITPR3—type 1 diabetes mellitus	0.000592	0.00102	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFIH1—type 1 diabetes mellitus	0.000588	0.00101	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000578	0.000995	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—type 1 diabetes mellitus	0.000557	0.000959	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2—type 1 diabetes mellitus	0.000554	0.000955	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—INS—type 1 diabetes mellitus	0.000541	0.000933	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PTPN2—type 1 diabetes mellitus	0.000538	0.000927	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—B2M—type 1 diabetes mellitus	0.000532	0.000916	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000531	0.000915	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000522	0.000899	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ALB—type 1 diabetes mellitus	0.000496	0.000855	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000494	0.00085	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00048	0.000827	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000476	0.00082	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NOS3—type 1 diabetes mellitus	0.000475	0.000818	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000474	0.000816	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000472	0.000813	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.00047	0.00081	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	0.000467	0.000804	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-E—type 1 diabetes mellitus	0.000463	0.000797	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000459	0.000791	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000454	0.000782	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000454	0.000782	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTLA4—type 1 diabetes mellitus	0.000446	0.000768	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000427	0.000735	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD79A—type 1 diabetes mellitus	0.000425	0.000733	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PRKCQ—type 1 diabetes mellitus	0.000417	0.000719	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—VAV1—type 1 diabetes mellitus	0.000405	0.000698	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000392	0.000676	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HBA2—type 1 diabetes mellitus	0.000391	0.000674	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000383	0.00066	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000368	0.000634	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000367	0.000632	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000361	0.000622	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000361	0.000622	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00036	0.000621	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000358	0.000617	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000358	0.000617	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD86—type 1 diabetes mellitus	0.000353	0.000609	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD40LG—type 1 diabetes mellitus	0.000347	0.000597	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000344	0.000592	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000344	0.000592	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD8A—type 1 diabetes mellitus	0.000343	0.00059	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-B—type 1 diabetes mellitus	0.00033	0.000568	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	0.000326	0.000562	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000319	0.00055	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ERBB3—type 1 diabetes mellitus	0.000319	0.000549	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000314	0.000542	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000313	0.000539	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2RA—type 1 diabetes mellitus	0.000309	0.000532	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-A—type 1 diabetes mellitus	0.000305	0.000526	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CRP—type 1 diabetes mellitus	0.000291	0.000502	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00028	0.000483	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000279	0.000481	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00027	0.000465	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000262	0.000451	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000261	0.00045	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD80—type 1 diabetes mellitus	0.000258	0.000444	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000252	0.000435	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000237	0.000409	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000229	0.000394	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000226	0.000389	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TYK2—type 1 diabetes mellitus	0.000218	0.000375	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000217	0.000374	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000213	0.000367	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000206	0.000355	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNG—type 1 diabetes mellitus	0.000204	0.000351	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000203	0.000349	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	0.0002	0.000345	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.0002	0.000344	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	0.000199	0.000343	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000198	0.000341	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD4—type 1 diabetes mellitus	0.000197	0.000339	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000196	0.000337	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000193	0.000333	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.000186	0.00032	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—type 1 diabetes mellitus	0.000182	0.000313	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2—type 1 diabetes mellitus	0.000181	0.000312	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000171	0.000295	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000169	0.000291	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000167	0.000287	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	0.000161	0.000278	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000159	0.000274	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INS—type 1 diabetes mellitus	0.000158	0.000271	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	0.000156	0.000269	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—STAT3—type 1 diabetes mellitus	0.000152	0.000263	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000152	0.000262	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000141	0.000242	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—EGFR—type 1 diabetes mellitus	0.000139	0.000239	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000138	0.000238	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000138	0.000237	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	0.000132	0.000227	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000127	0.00022	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000117	0.000202	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000117	0.000202	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000109	0.000188	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	0.000108	0.000185	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—type 1 diabetes mellitus	0.000106	0.000183	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	0.000101	0.000174	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	0.000101	0.000173	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	9.88e-05	0.00017	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.85e-05	0.00017	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	9.19e-05	0.000158	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	9.11e-05	0.000157	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.96e-05	0.000154	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INS—type 1 diabetes mellitus	8.76e-05	0.000151	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	8.65e-05	0.000149	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	8.6e-05	0.000148	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	8.44e-05	0.000145	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	8.03e-05	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	7.87e-05	0.000136	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.78e-05	0.000134	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	7.68e-05	0.000132	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—type 1 diabetes mellitus	6.88e-05	0.000119	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	6.73e-05	0.000116	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	6.66e-05	0.000115	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	5.69e-05	9.81e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	4.42e-05	7.62e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	4.06e-05	6.99e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	3.88e-05	6.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.78e-05	6.51e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	3.47e-05	5.97e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	3.31e-05	5.71e-05	CbGpPWpGaD
